Genetic Technologies - M&A Summary and Business Overview

Life ScienceCompany

Genetic Technologies M&A Summary

Genetic Technologies has acquired 2 companies, including 2 in the last 5 years. A total of 1 acquisition came from private equity firms.

Genetic Technologies’ largest acquisition to date was in 2021, when it acquired EasyDNA for $4M. Genetic Technologies has acquired in 1 US state, and 2 countries. The Company’s most targeted sectors include life science (100%).

Genetic Technologies Business Overview

Where is Genetic Technologies headquartered?

Genetic Technologies is headquartered in Fitzroy, Australia.

What is Genetic Technologies’ revenue?

Genetic Technologies disclosed revenue of 9M USD for 2020 and 25M USD for 2019.

What sector is Genetic Technologies in?

Genetic Technologies is a life science company.

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity2
  • Total Sectors Invested 1
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 1

Genetic Technologies

Genetic Technologies Ltd.

60-66 Hanover Street,
Fitzroy, VIC 3065
Australia,
61 3 8412 7000
www.gtglabs.com

Genetic Technologies is a diversified molecular diagnostics company. GTG offers cancer predictive testing and assessment tools to help physicians proactively manage patient health. The Company’s lead products GeneType for Breast Cancer for non-hereditary breast cancer and GeneType for Colorectal Cancer have clinically validated risk assessment tests and are first in class. Genetic Technologies is developing a pipeline of risk assessment products. Genetic Technologies is based in Fitzroy, Australia.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.4/yr) # - - 1 1 - - 2
vol $4M $4M
Sell (0.0/yr) # - - - - - - 0
  2

Most Recent M&A

Company Date Value Type
AffinityDNA 2022-07-14 - Add-on Acquisition
East Sussex, United Kingdom · www.affinitydna.co.uk
EasyDNA 2021-07-19 4M USD Add-on Acquisition
Elk Grove, California · www.easy-dna.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 2 (100%) 4M (100%) - -
Total 2 $4M - -

By Geo

State/Country Buy Value Sell Value
United Kingdom 1 - - -
United States 1 4M - -
  California 1 4M - -
Domestic - - - -
Cross-border 2 (100%) 4M (100%) - -
Total 2 $4M - -

Deal Values

buy # Total
< $100M 1 $4M
TOTAL $4M
Largest EasyDNA
$4M (2021-07-19)

M&A Connections

Deals
Acquired from
Investor(s)
50%
1 (50%)

 Subscribe to unlock this and 202,005
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Genetic Technologies

Life Science Companies , Australia Companies